Welcome to the inaugural Private Markets Update, which highlights developments in the European private markets, covering the issues that matter to investors in alternative assets. Touching on themes as diverse as predictions...more
5/31/2023
/ Acquisitions ,
Capital Markets ,
Cross-Border ,
EU ,
FinTech ,
Germany ,
Investment ,
Investors ,
Mergers ,
National Security ,
OECD ,
Pillar 2 ,
Private Equity ,
Private Equity Funds ,
Restructuring ,
UK
Key Trends & Opportunities in Life Sciences and Healthcare Investing -
The current macroeconomic environment is creating challenges for healthcare and life sciences businesses, which have been impacted hard by wage...more
12/9/2022
/ Capital Markets ,
Digital Health ,
EU ,
Healthcare ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
Technology ,
UK
After an insightful conference in Cannes, our partners have compiled some of the key takeaways from IPEM 2022.
As well as exploring the private equity landscape in the UK, Germany, France and Italy, we also explore the...more
10/25/2022
/ Acquisitions ,
Debt ,
Economic Growth ,
Environmental Social & Governance (ESG) ,
EU ,
France ,
Funding ,
Germany ,
Healthcare ,
Investment ,
Investors ,
Italy ,
Mergers ,
Private Equity ,
Publicly-Traded Companies ,
Small and Medium-Sized Enterprises (SMEs) ,
UK ,
Venture Capital
As the world enters a phase of the global pandemic marked by an increasing rate of vaccinations, investors are looking for global (particularly, European) healthcare market opportunities. With the emergence of certain...more
9/9/2021
/ Buyers ,
Capital Markets ,
Coronavirus/COVID-19 ,
EBITDA ,
Environmental Social & Governance (ESG) ,
EU ,
Healthcare ,
Investment ,
Investors ,
Market Infrastructure ,
Private Equity ,
Sellers ,
Take-Private Transactions ,
UK
In a climate where there are so many unknown factors challenging valuation methodologies, we explore a number of mechanisms that European dealmakers may consider during the Coronavirus (COVID-19) pandemic in order to bridge...more
12/4/2020
/ Acquisitions ,
Buyers ,
Coronavirus/COVID-19 ,
Deferred Consideration ,
Earn-Outs ,
EBITDA ,
EU ,
Fairness Standard ,
Fixed Price Contracts ,
Global Dealmaking ,
Indemnity Insurance ,
Mergers ,
Sellers ,
Warranty Insurance
The requirement to stay at home is giving many of us the opportunity to undertake (or no excuse to ignore) the household and DIY tasks at home that have long been at the bottom of the to-do list. Similarly, directors,...more